Comparison of the effects of nitric oxide and peroxynitrite on the 12-lipoxygenase and cyclooxygenase metabolism of arachidonic acid in rabbit platelets

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 59, Issue 2, 1998, Pages 95-100

  Fujimoto, Y ^a   Tagano, S ^a   Ogawa, K ^a   Sakuma, S ^a   Fujita, T ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXY 2 OXO 3 (N METHYL 3 AMINOPROPYL) 3 METHYL 1 TRIAZENE; 12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; NITRIC OXIDE; PEROXYNITRITE; PROSTAGLANDIN SYNTHASE; SUPEROXIDE; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOCYTE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0031693806     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(98)90087-4     Document Type: Article

References (34)

1. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
2. Radomski M. W., Palmer R. M. J., Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639-646.
3. Sneddon J. M., Vane J. R. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1988; 85: 2800-2804.
4. Radomski M. W., Palmer R. M. J., Moncada S. An L-arginine/ nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193-5197.
5. Radomski M. W., Palmer R. M. J., Moncada S. Characterization of the L-arginine: nitric oxide pathway in human platelets. Br J Pharmacol 1990; 101: 325-328.
6. Marcus A. J, Silk S. T., Safier L. B., Ullmann H. L. Superoxide production and reducing activity in human platelets. J Clin Invest 1977; 59: 149-158.
7. Marcus A. J. Pathways of oxygen utilization by stimulated platelets and leukocytes. Semin Haematol 1979; 16: 188-195.
8. Huie R. E., Padmaja S. The reaction rate of nitric oxide with superoxide. Free Rad Res Commun 1993; 18: 195-199.
9. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994; 350: 9-12.
10. White C. R., Brock T. A., Chang L. Y. et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 1994; 91: 1044-1048.
11. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
12. Moro M. A, Darley-Usmar V. M., Goodwin D. A. et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA 1994; 91: 6702-6706.
13. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 1974; 71: 3400-3404.
14. Dutilh C. E., Haddeman E., Jouvenaz G. H., Ten Hoor F., Nugteren D. H. Study of the two pathways for archidonate oxygenation in blood platelets. Lipids 1978; 14: 241-246.
15. Sekiya P., Takagi J., Usui T., Kawajiri K., Kobayashi Y., Sato Y. 12s-Hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation. Biochem Biophys Res Commun 1991; 179: 345-351.
16. Turner S. R., Tainer J. A., Lynn W. S. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature 1975; 257: 680-681.
17. Nakao J., Ito H., Chang W. C., Koshihara Y., Murota S. Aortic smooth muscle cell migration caused by platelet-derived growth factor is mediated by lipoxygenase product(s) of arachidonic acid. Biochem Biophys Res Commun 1983; 112: 866-871.
18. Nakatsuka M., Osawa Y. Selective inhibition of the 12-lipoxygenase pathway of arachidonic acid metabolism by L-arginine or sodium nitroprusside in intact human platelets. Biochem Biophys Res Commun 1994; 200: 1630-1634.
19. Hrabie J. A., Klose J. R., Wink D. A., Keefer L. K. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 1993; 58: 1472-1476.
20. Fujimoto Y., Nakatani E., Minamino H., Takahashi M., Sakuma S., Fujita T. Effective use of rabbit gastric antral mucosal slices in prostaglandin synthesis and metabolism studies. Biochim Biophys Acta 1990; 1044: 65-69.
21. Tsunomori M., Fujimoto Y., Muta E., Nishida H., Sakuma S., Fujita T. 15-Hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid. Biochim Biophys Acta 1996; 1300: 171-176.
22. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 1974; 26: 33-67.
23. Hope W. C., Welton A. F., Fiedler-Nagy C., Batula-Bernardo C., Coffey J. W. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. Biochem Pharmacol 1983; 32: 367-371.
24. Nakadate T., Yamamoto S., Aizu E., Kato R. Inhibition of 12-O-tetra-decanoylphorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipoxygenase inhibitors. Japan J Pharmacol 1985; 38: 161-168.
25. Fujimoto Y., Takai S., Matsuno K. et al. Effect of tert-butyl hydroperoxide on cyclooxygenase and lipoxygenase metabolism of arachidonic acid in rabbit platelets. Prostaglandins Leukot Essent Fatty Acids 1992; 47: 259-264.
26. •NO through a radical reaction. Biochemistry 1993; 32: 827-832.
27. Yoshida M., Akaike T., Wada Y. et al. Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun 1994; 202: 923-930.
28. Fridovich I. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J Biol Chem 1970; 245: 4053-4057.
29. Sumiya T., Fujimoto Y., Nishida H., Morikawa Y., Sakuma S., Fujita T. Effects of reactive oxygen species on arachidonic acid metabolism in rabbit platelets. Free Rad Biol Med 1993; 15: 101-104.
30. Salvemini D., Misko T. P., Masferrer J. L., Seibert K, Currie M. G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993; 90: 7240-7244.
31. 2 production by vascular smooth muscle cells. Biochem Biophys Res Commun 1993; 194: 420-424.
32. Kanner J., Harel S., Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 1992; 27: 46-49.
33. Tsai A. L., Wei C., Kulmacz R. J. Interaction between nitric oxide and prostaglandin H synthase. Arch Biochem Biophys 1994; 313: 367-372.
34. Moncada S., Radomski M. W., Palmer R. M. J. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37: 2495-2501.